https://www.selleckchem.com/pr....oducts/cerdulatinib.
This study explored that highly significant result for BPS, BPD, FBS and HbA c, whereas the significant results were obtained when RBS is compared with LOS and treatment costs. Our study concluded that mean difference of 9.24 $ in patients having FBS was 261-290mg/dL and 290mg/dL. The LOS is increased by 6.57days for patients with BPS between 140 and 159mmHg compared with BPS between 180 and 209 and above mmHg, which lowers treatment costs by -21.31$. 290 mg/dL. The LOS is increased by 6.57 days for patients with BPS between 14
Like
Comment
Share
